Elicio Therapeutics Management
Management criteria checks 1/4
Elicio Therapeutics' CEO is Bob Connelly, appointed in Oct 2018, has a tenure of 5.58 years. directly owns 25.39% of the company’s shares, worth $25.04M. The average tenure of the management team and the board of directors is 2.3 years and 2.7 years respectively.
Key information
Bob Connelly
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 5.6yrs |
| CEO ownership | 25.4% |
| Management average tenure | 2.3yrs |
| Board average tenure | 2.7yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | -US$35m |
| Sep 30 2023 | n/a | n/a | -US$33m |
| Jun 30 2023 | n/a | n/a | -US$29m |
| Mar 31 2023 | n/a | n/a | -US$29m |
| Dec 31 2022 | n/a | n/a | -US$28m |
| Sep 30 2022 | n/a | n/a | -US$28m |
| Mar 31 2022 | n/a | n/a | -US$27m |
| Dec 31 2021 | n/a | n/a | -US$26m |
| Mar 31 2021 | n/a | n/a | -US$19m |
| Dec 31 2020 | US$872k | US$450k | -US$16m |
Compensation vs Market: Insufficient data to establish whether Bob's total compensation is reasonable compared to companies of similar size in the US market.
Compensation vs Earnings: Insufficient data to compare Bob's compensation with company performance.
CEO
Bob Connelly (63 yo)
5.6yrs
Tenure
US$871,882
Compensation
Mr. Robert T. Connelly, also known as Bob, has been Chief Executive Officer and Director of Elicio Therapeutics Inc. since October 2018 and serves as its President. He served as a Director of Anchiano Ther...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 5.6yrs | US$871.88k | 25.39% $ 25.0m | |
| Executive VP | 4.6yrs | US$589.00k | 0% $ 0 | |
| Co-Founder | no data | no data | no data | |
| Chief Financial Officer | less than a year | no data | no data | |
| Senior Vice President of Operations & Human Resources | 4.3yrs | no data | no data | |
| Chief Scientific Officer | 2.3yrs | no data | no data | |
| General Counsel | 1.3yrs | no data | no data | |
| Senior Vice President of Clinical Development | 3.3yrs | no data | no data | |
| VP & Head of Regulatory Affairs | 2yrs | no data | no data | |
| Senior Vice President of Biometrics | 1.3yrs | no data | no data |
2.3yrs
Average Tenure
52.5yo
Average Age
Experienced Management: ELTX's management team is considered experienced (2.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 5.6yrs | US$871.88k | 25.39% $ 25.0m | |
| Co-Founder | no data | no data | no data | |
| Chairman & Member of Scientific Advisory Board | 7.3yrs | US$62.05k | 0% $ 0 | |
| Director | less than a year | no data | no data | |
| Independent Director & Member of Scientific Advisory Board | 6.3yrs | US$63.93k | 0% $ 0 | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Director | less than a year | no data | 1.17% $ 1.2m | |
| Independent Director | 3.8yrs | US$38.68k | 0% $ 0 | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Director | 1.6yrs | no data | 18.74% $ 18.5m | |
| Director | less than a year | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data |
2.7yrs
Average Tenure
64yo
Average Age
Experienced Board: ELTX's board of directors are not considered experienced ( 2.7 years average tenure), which suggests a new board.